Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy

The combination of chemotherapeutic drug paclitaxel (PTX) and VEGF siRNA could inhibit cancer development with synergistic efficacy. However, efficient and safe delivery systems with high encapsulation efficiency of PTX and a long-time release of drugs are urgently needed. In this study, novel nanop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Deliv
Main Authors: Zhang, Chuanmin, Zhao, Yinan, Zhang, Enxia, Jiang, Meilin, Zhi, Defu, Chen, Huiying, Cui, Shaohui, Zhen, Yuhong, Cui, Jingnan, Zhang, Shubiao
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594708/
https://ncbi.nlm.nih.gov/pubmed/33096948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2020.1827085
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados